Scott Craig M, Kruse Kristina B, Schmidt Béla Z, Perlmutter David H, McCracken Ardythe A, Brodsky Jeffrey L
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Mol Biol Cell. 2007 Oct;18(10):3776-87. doi: 10.1091/mbc.e07-01-0034. Epub 2007 Jul 18.
Antitrypsin deficiency is a primary cause of juvenile liver disease, and it arises from expression of the "Z" variant of the alpha-1 protease inhibitor (A1Pi). Whereas A1Pi is secreted from the liver, A1PiZ is retrotranslocated from the endoplasmic reticulum (ER) and degraded by the proteasome, an event that may offset liver damage. To better define the mechanism of A1PiZ degradation, a yeast expression system was developed previously, and a gene, ADD66, was identified that facilitates A1PiZ turnover. We report here that ADD66 encodes an approximately 30-kDa soluble, cytosolic protein and that the chymotrypsin-like activity of the proteasome is reduced in add66Delta mutants. This reduction in activity may arise from the accumulation of 20S proteasome assembly intermediates or from qualitative differences in assembled proteasomes. Add66p also seems to be a proteasome substrate. Consistent with its role in ER-associated degradation (ERAD), synthetic interactions are observed between the genes encoding Add66p and Ire1p, a transducer of the unfolded protein response, and yeast deleted for both ADD66 and/or IRE1 accumulate polyubiquitinated proteins. These data identify Add66p as a proteasome assembly chaperone (PAC), and they provide the first link between PAC activity and ERAD.
抗胰蛋白酶缺乏症是青少年肝病的主要病因,它由α1蛋白酶抑制剂(A1Pi)的“Z”变体表达引起。A1Pi由肝脏分泌,而A1PiZ从内质网(ER)逆向转运并被蛋白酶体降解,这一过程可能抵消肝脏损伤。为了更好地确定A1PiZ降解的机制,先前开发了一种酵母表达系统,并鉴定出一个促进A1PiZ周转的基因ADD66。我们在此报告,ADD66编码一种约30 kDa的可溶性胞质蛋白,并且在add66Δ突变体中蛋白酶体的胰凝乳蛋白酶样活性降低。这种活性降低可能源于20S蛋白酶体组装中间体的积累或组装好的蛋白酶体的质量差异。Add66p似乎也是蛋白酶体的底物。与其在内质网相关降解(ERAD)中的作用一致,在编码Add66p和Ire1p(未折叠蛋白反应的转导子)的基因之间观察到合成相互作用,并且同时缺失ADD66和/或IRE1的酵母会积累多聚泛素化蛋白。这些数据将Add66p鉴定为蛋白酶体组装伴侣(PAC),并提供了PAC活性与ERAD之间的首个联系。